RNAi modulation of RSV and therapeutic uses thereof

Details for Australian Patent Application No. 2010224450 (hide)

Owner Alnylam Pharmaceuticals, Inc.

Inventors Meyers, Rachel

Agent FB Rice

Pub. Number AU-A-2010224450

Parent 2006203934

Filing date 28 September 2010

Wipo publication date 21 October 2010

International Classifications

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

A61K 31/70 (2006.01) - Carbohydrates

Event Publications

14 October 2010 Complete Application Filed

21 October 2010 Application Open to Public Inspection

  Published as AU-A-2010224450

12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

19 May 2011 Corrigenda

  Applications Lapsed, Refused or Withdrawn, Patents Ceased or Expired - 2010 Delete all reference to Application No. 2010224450.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010224451-Display of bonus game progression in reel-type games

2010224449-Apparatus and method for manipulating a component of a wind turbine